Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
117.56
+1.65 (1.42%)
May 12, 2026, 10:16 AM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Filtration Products Revenue
-402.79M372.96M
Filtration Products Revenue Growth
-8.00%9.25%
Chromatography Products Revenue
-153.18M122.81M
Chromatography Products Revenue Growth
-24.73%-3.02%
Process Analytics Products Revenue
-81.24M59.30M
Process Analytics Products Revenue Growth
-36.99%4.37%
Proteins Products Revenue
-97.44M74.43M
Proteins Products Revenue Growth
-30.92%-28.07%
Other Products Revenue
-3.32M4.68M
Other Products Revenue Growth
--29.04%26.87%
Total Product Revenue
763.03M737.96M634.18M
Total Product Revenue Growth
3.40%16.36%0.35%
Royalty and Other Revenue
305.00K296.00K261.00K
Royalty and Other Revenue Growth
3.04%13.41%-31.85%
Revenue (Total)
763.34M738.26M634.44M
Revenue (Total) Growth
3.40%16.36%0.33%
Updated May 6, 2026. Data Source: Fiscal.ai.